PSYCHOPHARMACOLOGICAL DRUGS ADVISORY COMMITTEE
July 19, 2000
NDA 20-825: Zeldox (ziprasidone hydrochloride capsules)
Slides
Edmund P Harrigan, MD, Pfizer Global Research & Development ppt htm
Introduction, Thomas Laughren, MD, FDA htm
Background on QTc Prolongation, Arthur Moss, MD, Rochester Medical Center ppt htm
Clinical Important QT Interval Prolongation with Three Antipsychotics: Thioridazine, Pimozine, Sertindole, G M Dubitsky, MD, FDA PDF
Cardiovascular Drugs That Prolong the QT Interval, Douglas C Throckmorton, MD, FDA ppt htm
Assessing Cardiac Safety of Second-generation Antihistamines, Badrul A Chowdhury, MD, PhD, FDA ppt htm
QTc and Quinolones: Recent Regulatory Actions, Joyce Korvick MD, MPH, FDA ppt htm
Risk Intervention Study: Cisapride, Evelyn M Rodriguez, MD, MPH, FDA ppt htm
Open Public Hearing Speakers
Jacqueline Shannon, President, National Alliance for the Mentally Ill pdf
Shannon Flynn, Consumer Member, National Alliance for the Mentally Ill pdf